Logo image
Se connecter
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
Article de revue   Avec comité de lecture

Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study

Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ryussen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling et Cédric Lukas
Rheumatic & musculoskeletal diseases open, Vol.10(1), p.e003942
Short report
29/02/2024
PMID: 38428974

Résumé

Spondyloarthritis

Indicateurs

1 Consultations de la notice

Détails

Logo image